This inventor holds 1 USPTO granted patent. Top assignee: Paul Scherrer Institut. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Joerg Standfuss: Innovator in GPCR Research
Introduction
Joerg Standfuss is a prominent inventor based in Brugg AG, Switzerland. He has made significant contributions to the field of G protein-coupled receptors (GPCRs) through his innovative research and patented methodologies. His work focuses on understanding the binding mechanisms of ligands to GPCRs at a molecular level.
Latest Patents
Standfuss holds a patent titled "Method for determining mutateable ligand-GPCR binding at single amino acid resolution and pairs of mutated ligand and GPCR." This patent outlines a method for determining the binding ability of GPCRs and mutateable ligands. The process involves using a microtiter plate with an array of wells containing GPCR or rhodopsin, along with parent ligand mutants. The method allows for the assessment of binding strength compared to standard ligands, providing insights into critical interactions within the arrestin polar core and C-tail during activation. This innovative approach has implications for diagnostics and therapeutic interventions.
Career Highlights
Standfuss is affiliated with the Paul Scherrer Institut, where he conducts his research. His work has led to the development of functional maps that reveal essential interactions in GPCRs, enhancing the understanding of ligand binding and receptor activation. His research contributes to the broader field of molecular biology and pharmacology.
Collaborations
Standfuss collaborates with notable colleagues, including Martin Ostermaier and Gebhard Schertler. Their combined expertise fosters advancements in GPCR research and the development of new methodologies.
Conclusion
Joerg Standfuss is a key figure in the field of GPCR research, with a focus on innovative methods for understanding ligand binding. His contributions through patents and collaborations continue to shape the landscape of molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
